Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

IPOs Remain At Historic Lows In The 3rd Quarter

Published 10/05/2016, 03:29 AM
Updated 05/14/2017, 06:45 AM

IPOs Remain At Historic Lows In Q3 by Andrew Birstingl, Research Analyst – FactSet

The number of companies going public on United States exchanges amounted to 35 in the third quarter, which represented a 16.7% uptick from the year-ago quarter (30 IPOs). Despite the increase, this number still trails the average third quarter IPO count going back to 2000 (39 IPOs). The Q3 amount also represented an increase from the 31 companies going public during Q2. During the first three quarters of this year, the number of initial public offerings stood at 73, which was a 45% decline from the same time period a year ago. This marked the lowest IPO count through the first three quarters of a year since 2009, when only 33 firms went public.

IPO Activity: Quarterly

Gross proceeds (including over-allotment) from initial public offerings increased 29.4% year-over-year in Q3 to $6.7 billion. This value still lags the average third quarter gross proceeds total going back to 2000 ($10 billion). Similar to IPO volume, gross proceeds from initial public offerings through the first three quarters of 2016 ($13.1 billion) marked the lowest value since 2009, when the aggregate amount raised stood at $9.4 billion through Q3. Gross proceeds through the end of Q3 also marked a 47.6% decline compared to the same time period a year ago.

Health Technology Continues to Dominate IPO Volume

Of the 35 initial public offerings in Q3, 11 came from the Health Technology sector, which was the highest representation of any group. The third quarter marked the 11th consecutive quarter that the Health Technology group led all FactSet sectors in IPO volume. Looking at IPO volume this year through the end of Q3, 30 of 73 companies going public were part of the Health Technology group, with half of those coming from the Biotechnology industry, and another 40% coming from the Major Pharmaceuticals industry.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Health Technolgy Sector And Biotechnology Industry

Despite the Health Technology sector clearly dominating in terms of the number of IPOs this year, the year-to-date volume is nowhere near that of the last two years. During the first three quarters of 2014 and 2015, the number of firms from this group going public stood at 80 and 58, respectively.

Technology Services Leads Gross Proceeds

During the third quarter, the Technology Services sector led all groups in terms of aggregate gross proceeds from initial public offerings. Gross proceeds from the six IPOs in the sector amounted to $1.9 billion, which represented an uptick from the mere $119 million raised in the year-ago quarter from just a single company.

Technology Services Sector

Line Corp (NYSE:LN) was the top contributor in Q3, as the Japanese tech company raised $1.3 billion for its IPO, more than any other company. This was the largest amount raised by an initial public offering in the Technology Services group since First Data Corp raised $2.8 billion for its offering back in October 2015. Within the sector, Nutanix Inc (NASDAQ:NTNX) was the second major contributor in terms of amount raised. Gross proceeds for the enterprise virtualization and storage solutions provider amounted to $238 million.

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.